CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group
- PMID: 7906809
CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group
Abstract
Pre-eclampsia is a common and serious complication of pregnancy that affects both mother and child. Review of previous small trials of antiplatelet therapy, particularly low-dose aspirin, suggested reductions of about three-quarters in the incidence of pre-eclampsia and some avoidance of intrauterine growth retardation (IUGR), but larger trials have not confirmed these results. In our multicentre study 9364 women were randomly assigned 60 mg aspirin daily or matching placebo. 74% were entered for prophylaxis of pre-eclampsia, 12% for prophylaxis of IUGR, 12% for treatment of pre-eclampsia, and 3% for treatment of IUGR. Overall, the use of aspirin was associated with a reduction of only 12% in the incidence of proteinuric pre-eclampsia, which was not significant. Nor was there any significant effect on the incidence of IUGR or of stillbirth and neonatal death. Aspirin did, however, significantly reduce the likelihood of preterm delivery (19.7% aspirin vs 22.2% control; absolute reduction of 2.5 [SD 0.9] per 100 women treated; 2p = 0.003). There was a significant trend (p = 0.004) towards progressively greater reductions in proteinuric pre-eclampsia the more preterm the delivery. Aspirin was not associated with a significant increase in placental haemorrhages or in bleeding during preparation for epidural anaesthesia, but there was a slight increase in use of blood transfusion after delivery. Low-dose aspirin was generally safe for the fetus and newborn infant, with no evidence of an increased likelihood of bleeding. Our findings do not support routine prophylactic or therapeutic administration of antiplatelet therapy in pregnancy to all women at increased risk of pre-eclampsia or IUGR. Low-dose aspirin may be justified in women judged to be especially liable to early-onset pre-eclampsia severe enough to need very preterm delivery. In such women it seems appropriate to start low-dose aspirin prophylactically early in the second trimester.
Comment in
-
CLASP: millstone or milestone?Lancet. 1994 Mar 12;343(8898):616-7. doi: 10.1016/s0140-6736(94)92630-1. Lancet. 1994. PMID: 7906806 No abstract available.
Similar articles
-
Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial.Croat Med J. 2005 Oct;46(5):826-31. Croat Med J. 2005. PMID: 16158479 Clinical Trial.
-
[Prevention of pre-eclampsia by low-dose acetylsalicylic acid--a critical appraisal].Z Geburtshilfe Neonatol. 2002 Jul-Aug;206(4):125-30. doi: 10.1055/s-2002-33667. Z Geburtshilfe Neonatol. 2002. PMID: 12198588 Review. German.
-
Antiplatelet agents for preventing and treating pre-eclampsia.Cochrane Database Syst Rev. 2000;(2):CD000492. doi: 10.1002/14651858.CD000492. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2007 Jul 18;(2):CD000492. doi: 10.1002/14651858.CD000492.pub2. PMID: 10796208 Updated. Review.
-
Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications.Br J Obstet Gynaecol. 1998 Mar;105(3):286-92. doi: 10.1111/j.1471-0528.1998.tb10088.x. Br J Obstet Gynaecol. 1998. PMID: 9532988 Clinical Trial.
-
ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevenção da Pré-eclampsia com Aspirina) Collaborative Group.Br J Obstet Gynaecol. 1996 Jan;103(1):39-47. doi: 10.1111/j.1471-0528.1996.tb09513.x. Br J Obstet Gynaecol. 1996. PMID: 8608096 Clinical Trial.
Cited by
-
Barriers and facilitators of adherence to low-dose aspirin during pregnancy: A co-produced systematic review and COM-B framework synthesis of qualitative evidence.PLoS One. 2024 May 3;19(5):e0302720. doi: 10.1371/journal.pone.0302720. eCollection 2024. PLoS One. 2024. PMID: 38701053 Free PMC article.
-
Aspirin for preeclampsia prevention in low- and middle-income countries: mind the gaps.AJOG Glob Rep. 2024 Apr 3;4(2):100352. doi: 10.1016/j.xagr.2024.100352. eCollection 2024 May. AJOG Glob Rep. 2024. PMID: 38694484 Free PMC article.
-
Review of Medically Indicated Preterm Births Due to Hypertensive Disorders in Pregnancy at a Tertiary Hospital in Abuja: Maternal Characteristics and Neonatal Outcome.Niger Med J. 2022 Apr 25;62(2):79-84. eCollection 2021 Mar-Apr. Niger Med J. 2022. PMID: 38505568 Free PMC article.
-
The impact of long-term aspirin use on the patients undergoing shoulder arthroplasty.J Orthop Surg Res. 2023 Nov 23;18(1):894. doi: 10.1186/s13018-023-04374-4. J Orthop Surg Res. 2023. PMID: 37993872 Free PMC article.
-
The impact of risk factors on aspirin's efficacy for the prevention of preterm birth.Am J Obstet Gynecol MFM. 2023 Oct;5(10):101095. doi: 10.1016/j.ajogmf.2023.101095. Epub 2023 Aug 12. Am J Obstet Gynecol MFM. 2023. PMID: 37574046 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical